Title:
PHARMACEUTICAL FOR TREATING FATTY LIVER DISEASES
Document Type and Number:
WIPO Patent Application WO/2021/235508
Kind Code:
A1
Abstract:
Provided is a pharmaceutical composition for treating and/or preventing fatty liver diseases, in particular, nonalcoholic fatty liver diseases, said pharmaceutical composition having excellent ACC2-selective inhibitory action without accompanying side effects such as an increase in plasma triglycerides or a decrease in platelet concentration. This pharmaceutical composition for treating and/or preventing fatty liver diseases comprises a compound represented by formula (I) or a pharmaceutically acceptable salt thereof [in formula (I): R1 represents a haloalkyl or a nonaromatic carbocyclic group; R2 represents a hydrogen atom or a halogen; R3 represents a halogen; ring A is a group represented by formula (II); -L1- represents -O-(CH2)-, -(CH2)2-, etc.; R4 represents an alkyl or a haloalkyl; and R5 represents an alkylcarbonyl or carbamoyl].
Inventors:
YUKIOKA HIDEO (JP)
SHIMAZAKI ATSUYUKI (JP)
HAMADA TADATERU (JP)
SHIMAZAKI ATSUYUKI (JP)
HAMADA TADATERU (JP)
Application Number:
PCT/JP2021/019088
Publication Date:
November 25, 2021
Filing Date:
May 20, 2021
Export Citation:
Assignee:
SHIONOGI & CO (JP)
International Classes:
A61K31/4184; A61K31/53; A61K31/573; A61K38/26; A61P1/16; A61P3/06; A61P3/10; A61P35/00; A61P43/00; C07D235/26; C07D405/12; C07J9/00
Domestic Patent References:
WO2016159082A1 | 2016-10-06 | |||
WO2019006324A1 | 2019-01-03 | |||
WO2015056782A1 | 2015-04-23 | |||
WO2013071169A1 | 2013-05-16 | |||
WO2016112305A1 | 2016-07-14 | |||
WO2011058474A1 | 2011-05-19 | |||
WO2015056782A1 | 2015-04-23 | |||
WO2016159082A1 | 2016-10-06 |
Foreign References:
JP2004523225A | 2004-08-05 | |||
JP2013542218A | 2013-11-21 | |||
JP2018501276A | 2018-01-18 | |||
US20140187633A1 | 2014-07-03 |
Other References:
"Isotopes in the Physical and Biomedical Sciences", vol. 1, 1987, article "Labeled Compounds (Part A"
"Design of Prodrugs", 1985, ELSEVIER
"Design of Prodrugs", 1985, ELSEVIER
Attorney, Agent or Firm:
SUGITA Ken-ichi et al. (JP)
Download PDF:
Previous Patent: MODIFIED ETHYLENE/VINYL ALCOHOL RESIN AND GAS-BARRIER MATERIAL
Next Patent: ANTIGEN-BINDING MOLECULE
Next Patent: ANTIGEN-BINDING MOLECULE